Literature DB >> 32888104

Comparative study of life satisfaction among patients with psoriasis versus healthy comparison group: the explanatory role of body image and resource profiles.

Marcin Rzeszutek1, Katarzyna Podkowa2, Małgorzata Pięta2, Daniel Pankowski3, Sylwia Cyran-Stemplewska4.   

Abstract

PURPOSE: The aim of the study was first to examine the heterogeneity of body image and resources, as described by the conservation of resources theory (COR), in a sample of psoriatic patients and explore whether heterogeneity within these variables explains the possible differences in levels of life satisfaction among the participants. Second, we aimed to investigate if life satisfaction level among the observed profiles of psoriatic patients, extracted on the basis of their body image and resources, differed from that of the healthy comparison group.
METHODS: The sample consisted of 735 participants, including 355 adults with a medical diagnosis of psoriasis and 380 healthy adults recruited from a non-clinical general population. Participants filled the Satisfaction with Life Scale, the Multidimensional Body-Self Relations Questionnaire and the COR evaluation questionnaire.
RESULTS: Latent profile analysis revealed four classes of psoriatic patients with different levels of resources and body image. The group with the highest level of resources and the most positive body image did not differ from the healthy comparison group regarding satisfaction with life. The group with the lowest level of resources and the most negative body image was characterized by the lowest satisfaction with life.
CONCLUSIONS: The results of our study may change the simplifying trend that highlights the traditionally very poor well-being of psoriatic patients. Moreover, the discovery of specific profiles of these patients, which differ with regard to psychological variables, can lead to rethinking contemporary forms of psychological counselling in psoriatic patients.

Entities:  

Keywords:  Body image; Latent profile analysis; Life satisfaction; Psoriasis; Resources

Year:  2020        PMID: 32888104      PMCID: PMC7847870          DOI: 10.1007/s11136-020-02621-3

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  38 in total

1.  The Satisfaction With Life Scale.

Authors:  E Diener; R A Emmons; R J Larsen; S Griffin
Journal:  J Pers Assess       Date:  1985-02

Review 2.  The psychosocial burden of psoriasis.

Authors:  Alexa B Kimball; Christine Jacobson; Stefan Weiss; Mary G Vreeland; Ying Wu
Journal:  Am J Clin Dermatol       Date:  2005       Impact factor: 7.403

3.  Two considerations for patients with psoriasis and their clinicians: what defines mild, moderate, and severe psoriasis? What constitutes a clinically significant improvement when treating psoriasis?

Authors:  G G Krueger; S R Feldman; C Camisa; M Duvic; J T Elder; A B Gottlieb; J Koo; J G Krueger; M Lebwohl; N Lowe; A Menter; W L Morison; J H Prystowsky; J L Shupack; J R Taylor; G D Weinstein; T L Barton; T Rolstad; R M Day
Journal:  J Am Acad Dermatol       Date:  2000-08       Impact factor: 11.527

4.  Toward a better understanding of social anxiety and depression in psoriasis patients: The role of determinants, mediators, and moderators.

Authors:  Patryk Łakuta; Hanna Przybyła-Basista
Journal:  J Psychosom Res       Date:  2017-01-10       Impact factor: 3.006

5.  Quality of life in 6497 Nordic patients with psoriasis.

Authors:  R Zachariae; H Zachariae; K Blomqvist; S Davidsson; L Molin; C Mørk; B Sigurgeirsson
Journal:  Br J Dermatol       Date:  2002-06       Impact factor: 9.302

6.  Suffering in psoriasis patients: its relation with illness severity and subjective well-being.

Authors:  J L M Reimus; A J J M Vingerhoets; P H G M Soons; M J Korstanje
Journal:  Int J Dermatol       Date:  2007-10       Impact factor: 2.736

7.  Social support and adaptation to the disease in men and women with psoriasis.

Authors:  Konrad Janowski; Stanisława Steuden; Aldona Pietrzak; Dorota Krasowska; Lukasz Kaczmarek; Ilona Gradus; Grażyna Chodorowska
Journal:  Arch Dermatol Res       Date:  2012-03-29       Impact factor: 3.017

8.  Itch, disease coping strategies and quality of life in psoriasis patients.

Authors:  Alicja Ograczyk; Joanna Miniszewska; Anna Kępska; Anna Zalewska-Janowska
Journal:  Postepy Dermatol Alergol       Date:  2014-10-22       Impact factor: 1.837

Review 9.  Psoriasis and Atopic Dermatitis.

Authors:  Christopher E M Griffiths; Peter van de Kerkhof; Magdalena Czarnecka-Operacz
Journal:  Dermatol Ther (Heidelb)       Date:  2017-02-01

10.  Nonadherence to psoriasis medication as an outcome of limited coping resources and conflicting goals: findings from a qualitative interview study with people with psoriasis.

Authors:  R J Thorneloe; C Bundy; C E M Griffiths; D M Ashcroft; L Cordingley
Journal:  Br J Dermatol       Date:  2016-12-17       Impact factor: 9.302

View more
  4 in total

1.  How important is subjective well-being for patients? A qualitative interview study of people with psoriasis.

Authors:  Antonia-Luise Newi; Athanasios Tsianakas; Sophia von Martial; Rachel Sommer; Christine Blome
Journal:  Qual Life Res       Date:  2022-08-10       Impact factor: 3.440

2.  Happiness and depression in psoriasis: a cross-sectional study in Germany.

Authors:  Alexander Zink; Maximilian C Schielein; Barbara Schuster; Corinna Peifer; Stefanie Ziehfreund; Linda Tizek; Tilo Biedermann
Journal:  Qual Life Res       Date:  2021-09-16       Impact factor: 3.440

3.  The potency of common proinflammatory cytokines measurement for revealing the risk and severity of anxiety and depression in psoriasis patients.

Authors:  Nannan Tong; Yu Zhang; Anping Yang; Xiaoli Dai; Siyu Hao
Journal:  J Clin Lab Anal       Date:  2022-08-09       Impact factor: 3.124

4.  The Impact of Stress-Coping Strategies and the Severity of Psoriasis on Self-Esteem, Illness Acceptance and Life Satisfaction.

Authors:  Beata Kowalewska; Elżbieta Krajewska-Kułak; Marek Sobolewski
Journal:  Dermatol Ther (Heidelb)       Date:  2022-01-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.